Showing results (1-10 of 281) with videos related to
Sort By:
Pageof 29
Methods in Molecular Biology (Clifton, N.J.)|December 4, 2013
Vaccine production: upstream processing with adherent or suspension cell linesYvonne Genzel, Jana Rödig, Erdmann Rapp, et al.Applied Microbiology and Biotechnology|July 24, 2012
CAP, a new human suspension cell line for influenza virus productionYvonne Genzel, Ilona Behrendt, Jana Rödig, et al.Proteomics|June 9, 2009
Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell linesDiana Vester, Erdmann Rapp, Dörte Gade, et al.Applied Microbiology and Biotechnology|July 10, 2010
MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivationYvonne Genzel, Christian Dietzsch, Erdmann Rapp, et al.Journal of Proteomics|May 4, 2010
Virus-host cell interactions in vaccine production cell lines infected with different human influenza A virus variants: a proteomic approachDiana Vester, Erdmann Rapp, Sabine Kluge, et al.Plos One|December 14, 2011
Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutininJana Verena Roedig, Erdmann Rapp, Dirk Höper, et al.Scientific Reports|March 5, 2021
Site-specific N-glycosylation analysis of animal cell culture-derived Zika virus proteinsAlexander Pralow, Alexander Nikolay, Arnaud Leon, et al.Vaccine|April 21, 2015
Monitoring changes in proteome during stepwise adaptation of a MDCK cell line from adherence to growth in suspensionSabine Kluge, Dirk Benndorf, Yvonne Genzel, et al.Vaccine|May 5, 2009
Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutininJana Schwarzer, Erdmann Rapp, René Hennig, et al.Expert Review of Vaccines|December 1, 2009
Continuous cell lines as a production system for influenza vaccinesYvonne Genzel, Udo ReichlPageof 29